BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12474238)

  • 1. Re: Cook et al. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 2002; 197: 188-193.
    Heenan PJ; Taran JM
    J Pathol; 2003 Jan; 199(1):132; author reply 132-3. PubMed ID: 12474238
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
    Cook MG; Spatz A; Bröcker EB; Ruiter DJ
    J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence of melanoma.
    Heenan PJ
    Pathology; 2004 Oct; 36(5):491-5. PubMed ID: 15370121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A; Ghazarian DM; McCready DR; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
    Shaw HM; McCarthy WH; Scolyer RA
    Cancer; 2002 Aug; 95(3):671-2; author reply 672-3. PubMed ID: 12209764
    [No Abstract]   [Full Text] [Related]  

  • 6. The natural course of cutaneous melanoma.
    Leiter U; Meier F; Schittek B; Garbe C
    J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of APAF-1 expression in human cutaneous melanoma progression.
    Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
    Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Completely regressed primary cutaneous malignant melanoma with metastases.
    Muniesa C; Ferreres JR; Moreno A; Marcoval J
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):327-8. PubMed ID: 18624860
    [No Abstract]   [Full Text] [Related]  

  • 9. [On metastatic melanomas of the brain].
    Zhukovitskiĭ IM
    Vrach Delo; 1966 Sep; 9():142-3. PubMed ID: 6001251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic factors in thin cutaneous malignant melanoma].
    Massi D; Franchi A; Santucci M
    Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease progression in patients with thin cutaneous melanomas.
    Nicolaou N; Morris A; Motley R
    Br J Dermatol; 2004 Jun; 150(6):1223; author reply 1224. PubMed ID: 15214924
    [No Abstract]   [Full Text] [Related]  

  • 12. [Melanocytoblastomas in women with special reference to the localization. 1. Comparative methodical studies of the pigmental reaction of primary tumors and metastases].
    Hoppe E; Wegewitz E; Hoppe D
    Radiobiol Radiother (Berl); 1969; 10(5):581-92. PubMed ID: 4903199
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9-11). American Joint Committee on Cancer.
    Balch CM; Mihm MC
    Ann Oncol; 2002 Jan; 13(1):175-6. PubMed ID: 11863103
    [No Abstract]   [Full Text] [Related]  

  • 14. The correlation of regression in primary melanoma with sentinel lymph node status.
    Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
    J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
    Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma].
    Tejera-Vaquerizo A; Barrera-Vigo MV; Fernández-Canedo I; Blázquez-Sánchez N; Mendiola-Fernández M; Fernández-Orland A; Bosch-García R; de Troya-Martín M; Herrera-Ceballos E
    Actas Dermosifiliogr; 2007 Oct; 98(8):531-8. PubMed ID: 17919427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological iconography No. 211. 2. Melanomalignoma on melanosis preblastomatosa circumscripta Dubreuilh with regional metastases].
    Grimmer H
    Z Haut Geschlechtskr; 1968 Nov; 43(22):Suppl:170-2. PubMed ID: 5714944
    [No Abstract]   [Full Text] [Related]  

  • 19. Histological types of polypoid cutaneous melanoma II.
    Knezević F; Duancić V; Sitić S; Horvat-Knezević A; Benković V; Ramić S; Kostović K; Ramljak V; Vrdoljak DV; Stanec M; Bozović A
    Coll Antropol; 2007 Dec; 31(4):1049-53. PubMed ID: 18217457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma.
    Cassarino DS; Cabral ES; Kartha RV; Swetter SM
    Arch Dermatol; 2008 Jan; 144(1):49-56. PubMed ID: 18209168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.